Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2014
06/05/2014US20140154234 Method for generating thrombin
06/05/2014US20140154233 Method of purifying therapeutic proteins
06/05/2014US20140154231 Process for separating proteins fibrinogen, factor xiii and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
06/05/2014US20140154229 Proteolytic extract from bromelain for the treatment of connective tissue disorders
06/05/2014US20140154216 Virus strains
06/05/2014US20140154215 Herpes virus strains
06/05/2014US20140154214 Selective glucagon-like-peptide-2 (glp-2) analogues
06/05/2014US20140154208 Novel [N-Me-4-hydroxyleucine]-9-Cyclosporin Analogues for Treatment and Prevention of Hepatitis C Infection
06/05/2014US20140154207 Kit containing stem cells and cytokines for use in attenuating immune responses
06/05/2014US20140154205 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
06/05/2014US20140154203 Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using The Same
06/05/2014DE102012022778A1 Medicine useful for treating cancer, heart attack and tuberculosis, comprises active ingredient e.g. theobromine which is alkaloid obtained from cocoa, lichenin which is antibiotic derived from oats and caffeine obtained from coffee
06/04/2014EP2738256A2 Use of the peptide gk-1 expressed in the filamentous phage m13 for preparing pharmaceutical products that increase the effectiveness of the immune response induced by vaccine antigens or pathogens
06/04/2014EP2738255A1 Erap1-derived peptide and use thereof
06/04/2014EP2737905A1 Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases
06/04/2014EP2737904A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
06/04/2014EP2737903A1 Antimicrobial activity enhancing agent
06/04/2014EP2737895A1 Microparticles with EGF, method of preparation and use
06/04/2014EP2737311A1 Assays to monitor bleeding disorders
06/04/2014EP2736920A1 Notch pathway signaling inhibitor compound
06/04/2014EP2736540A2 Switch costimulatory receptors
06/04/2014EP2736525A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
06/04/2014EP2736524A1 Purified proteins
06/04/2014EP2736523A1 Modulators of protease activated receptors
06/04/2014EP2736490A1 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
06/04/2014EP2736485A1 Aqueous solutions of lipophilic substances, in particular medicinal solutions
06/04/2014EP2736354A1 Use of citrulline and combination compound for improving male fertility
06/04/2014CN1867667B Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
06/04/2014CN103842517A Collagen 7 and related methods
06/04/2014CN103842373A Template -fixed peptidomimetics as inhibitors of FPR1
06/04/2014CN103842372A Cyclosporin derivatives
06/04/2014CN103842371A Silk-based bioactive oligopeptide compositions and manufacturing process therefor
06/04/2014CN103841991A Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
06/04/2014CN103841990A In vivo synthesis of elastic fiber
06/04/2014CN103841989A Submicron particles to decrease transfusion
06/04/2014CN103841988A Lixisenatide and metformin for treatment of diabetes type 2
06/04/2014CN103841987A Treatment of degenerative joint disease
06/04/2014CN103841979A Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
06/04/2014CN103841960A Method and formulation for inhalation
06/04/2014CN103841954A Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
06/04/2014CN103834677A Recombinant expression method for human cryptochrome protein I (hCRY1) and application of human cryptochrome protein I (hCRY1) in preparation of radiotherapy protective agent
06/04/2014CN103834623A Human-derived urate oxidases with catalytic activity
06/04/2014CN103834622A Recombinant PTD-Cu/Zn SOD (Protein Transduction Domain-Cu/Zn Superoxide Dismutase) protein and application thereof
06/04/2014CN103833857A Recombinant fusion protein hIFN gamma-MAP30 as well as preparation method and application of recombinant fusion protein hIFN gamma-MAP30
06/04/2014CN103833856A Fusion protein for inhibiting formation of TACI-BAFF complex and preparation method and application thereof
06/04/2014CN103833841A EXENDIN-4 analogue dimer and preparation method and application thereof
06/04/2014CN103833833A Self-assembled polypeptide, preparation method and application thereof
06/04/2014CN103833832A Melanocortin receptor-specific peptides
06/04/2014CN103833827A Amide compounds, medicine compositions, preparation method and application thereof
06/04/2014CN103833760A Piperazidines derivate
06/04/2014CN103830725A Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/04/2014CN103830721A Derivant of establishing rheumatoid arthritis animal model, preparation and application thereof
06/04/2014CN103830720A Medicine composition containing oxytocin
06/04/2014CN103830719A Methods for performing coronary artery bypass graft procedure
06/04/2014CN103830718A Pharmaceutical composition for treating oral ulcer
06/04/2014CN103830383A Metabolized conditioned growth medium and methods of use
06/04/2014CN103830205A Soluble thrombin nano-particle, and preparation method and application thereof
06/04/2014CN103830189A Recombinant insulin glargine preparation and preparation method thereof
06/04/2014CN103830180A Lysozyme hydrochloride oral spray and preparation method thereof
06/04/2014CN103830173A Preparation method of pidotimod dry suspension
06/04/2014CN103829241A Method for controlling protein peptic solidification
06/04/2014CN103169946B Application of Safenour cyclopeptide in oral insulin medicine for treating diabetes
06/04/2014CN103040852B Application of lysine as synergist for preparing antifungal drug
06/04/2014CN102924567B Peptide compound and preparation method and use of peptide compound
06/04/2014CN102863525B Recombinant human apoE peptide mimics, preparation method and application
06/04/2014CN102807605B Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof
06/04/2014CN102807604B N alpha-(1,3-dioxy-4,4,5,5-tetramethyl imidazoline-2-phenyl-4'-oxo acetyl)-N omega-fatty acyl-Lys-Arg-Gly-Asp-Val and preparation method and application thereof
06/04/2014CN102653783B Application of HVEM (herpesvirus entry mediator) gene in preparing product for liver cancer diagnosis and prognosis prediction
06/04/2014CN102585016B Immune fusion protein capable of inhibiting T and B lymphocyte functions and preparation method and application thereof
06/04/2014CN102558335B Gene recombinant VPAC2 receptor-specific agonist DBAYL and preparation method and application thereof
06/04/2014CN102516357B Polypeptide combined with A-beta amyloid and application thereof
06/04/2014CN102477085B Construction and application of Candida albican growth-related factor Cas5 mutant
06/04/2014CN102453089B Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate
06/04/2014CN102399285B Parathyroid hormone (PTH) derivative
06/04/2014CN102316892B Use of cardiotrophin- 1 for the treatment of metabolic diseases
06/04/2014CN102311493B Peptide inhibiting telomerase activity, its preparation method and application
06/04/2014CN102191233B Novel 10-23 deoxyribozyme analogue and application thereof
06/04/2014CN102026652B Thrombin inhibitor
06/04/2014CN102007144B Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
06/04/2014CN101951888B Enhancement of the efficacy of therapeutic proteins
06/04/2014CN101608201B Method for producing novel streptococcus thermophilus bacteriocin
06/04/2014CN101516387B Caspofungin formulations
06/04/2014CN101405019B Medicine for treating tumor and use thereof
06/04/2014CN101232895B Therapeutic peptides for the treatment of metastatic cancer
06/03/2014US8742092 RNA sequence-specific mediators of RNA interference
06/03/2014US8742091 Method of promoting nucleic acid transfer
06/03/2014US8742090 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
06/03/2014US8742084 Bioreactive agents
06/03/2014US8742079 Saccharide-containing protein conjugates and uses thereof
06/03/2014US8742072 Bone growth particles and osteoinductive composition thereof
06/03/2014US8742070 Method for selecting a candidate drug compound
06/03/2014US8742067 Anti-tumor drug, medicament, composition, and use thereof
06/03/2014US8742013 Synthesis of lipoamide-grafted high molecular compound and method therefor
06/03/2014US8741861 Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
06/03/2014US8741852 Peptides having antimicrobial activity
06/03/2014US8741851 Peptides having antimicrobial activity
06/03/2014US8741850 Compounds modulators of VEGF activity and uses thereof
06/03/2014US8741849 Kinase inhibitors and uses thereof
06/03/2014US8741848 Pharmaceutical composition of microspheres for preventing diabetic foot amputation
06/03/2014US8741847 Agent and methods for reducing inflammatory markers
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 3163